NCT01247896View on ClinicalTrials.gov

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Diabetes Mellitus, Type II
Interventions
DRUG

PF-05190457

Single Dose 2 mg

DRUG

PF-05190457

Single Dose 10 mg

DRUG

PF-05190457

Single Dose 30 mg

DRUG

PF-05190457

Single Dose 100 mg

DRUG

PF-05190457

Single Dose 300 mg

DRUG

PF-05190457

Single Dose 600 mg

DRUG

PF-05190457

Single Dose - to be determined with food

DRUG

PF-05190457

Single Dose - to be determined

DRUG

Placebo

Single Dose Placebo

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01247896 - Single Dose Escalation Study of PF-05190457 in Healthy Volunteers | Biotech Hunter | Biotech Hunter